Efficacy
PD, SD
DISEASE
Of the 5 patients who finished 2 cycles of treatment and underwent planned restaging scans and therefore were radiographically evaluable (all of whom were treated in the 600 mg BID dose de-escalation phase), 2 had stable disease (SD), one had partial response (PR) and 2 had progressive disease (PD) (